Placebo Responses in Trials of Parkinson’s Disease
Neurologic Clinics · 2026-02 · 44 (1) · 47-61
DOI: 10.1016/j.ncl.2025.08.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurologic Clinics, 2026-02. Verfasst von Surabhi Garg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson's Disease and Movement Disorders Clinic, Division of Neurology, Department of Medicine, The Ottawa Hospital, Civic Campus, C2 Neurosciences…. Hauptthemen laut MEDLINE: Parkinson Disease, Placebo Effect, Clinical Trials as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Parkinson's disease is well documented to be associated with a placebo response. The striatonigral degeneration and resulting dopamine deficiency make it a particularly compelling condition for studying placebo effects, which are most commonly explained by a hyperdopaminergic hypothesis. The placebo response can vary across different motor and nonmotor symptoms. Several factors may influence this response, including symptom severity, the presence of motor fluctuations, expectation of benefit, and the type of intervention. While minimizing placebo effects is essential in clinical trials-where strategies exist to reduce bias-a placebo response can be leveraged in clinical practice to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parkinson's Disease and Movement Disorders Clinic, Division of Neurology, Department of Medicine, The Ottawa Hospital, Civic Campus, C2 Neurosciences, 1053 Carling Avenue, Ottawa, Ontario K1Y 4E9, Canada.
- Parkinson's Disease and Movement Disorders Clinic, Division of Neurology, Department of Medicine, The Ottawa Hospital, Civic Campus, C2 Neurosciences, Room C2196, 1053 Carling Avenue, Ottawa, Ontario K1Y 4E9, Canada; Th…
Zitieren
APA
Garg, S., & Mestre, T. (2026). Placebo Responses in Trials of Parkinson’s Disease. Neurologic Clinics, 44(1), 47-61. https://doi.org/10.1016/j.ncl.2025.08.003
Vancouver
Garg S, Mestre T. Placebo Responses in Trials of Parkinson’s Disease. Neurologic Clinics. 2026;44(1):47-61. doi:10.1016/j.ncl.2025.08.003
BibTeX
@article{Garg2026,
author = {Garg, Surabhi and Mestre, Tiago},
title = {Placebo Responses in Trials of Parkinson’s Disease},
journal = {Neurologic Clinics},
year = {2026},
volume = {44},
number = {1},
pages = {47--61},
doi = {10.1016/j.ncl.2025.08.003}
}
EUVIMED